Health Care & Life Sciences » Pharmaceuticals | Indivior PLC

Indivior PLC

Indivior PLC ADR
Stock Exchange Other OTC
EPS
 $1.66
Market Cap
 $440.65 M
Shares Outstanding
 146.01 M
Public Float
 -
Indivior PLC
Stock Exchange Other OTC
EPS
 $0.33
Market Cap
 $445.14 M
Shares Outstanding
 728.1 M
Public Float
 -
Indivior PLC ADR
Stock Exchange Frankfurt Stock Exchange
EPS
 EUR1.43
Market Cap
 EUR370.86 M
Shares Outstanding
 145.66 M
Public Float
 -
Indivior PLC
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 728.31 M
Public Float
 -
Indivior PLC
Stock Exchange London Stock Exchange
EPS
 GBP0.25
Market Cap
 GBP352.25 M
Shares Outstanding
 730.03 M
Public Float
 724.64 M

Profile

Address
103-105 Bath Road
Slough Berkshire SL1 3UH
United Kingdom
Employees -
Website http://indivior.com/
Updated 07/08/2019
Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Financials

View All
Created with Highcharts 5.0.14Indivior PLCNet Income. Fiscal year is January-December. All values GBP Thousands.312 841312 841244 753244 753149 233149 23325 93925 93945 03745 037206 239206 2392013201420152016201720180100k200k300k400k
Created with Highcharts 5.0.14Indivior PLCSales/Revenue. Fiscal year is January-December. All values GBP Thousands.777 944777 944677 170677 170663 697663 697784 110784 110848 719848 719753 709753 7092013201420152016201720180200k400k600k800k1 000k

Howard H. Pien
Chairman
Shaun Thaxter
Chief Executive Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.